Skip to content

Clinical trials

Observational Obesity trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Observational Country / region: Singapore Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20141
20151
20181
20192
20211
20221
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University of Singapore3
Singapore General Hospital3
Nanyang Technological University1
National Heart Centre Singapore1
National University Hospital, Singapore1
Novena Medical Center1
Novo Nordisk A/S1
Sengkang General Hospital1
Yale-NUS College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity13
Overweight4
Alopecia1
Anxiety Disorders1
Diabetes, Gestational1
Insulin Resistance1
Metabolic Syndrome1
Obesity, Morbid1
Pediatric Obesity1
Sarcopenia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.